Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

192

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, gastroresistant	470,345 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	771,366 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	1,381,470 L.L
A02BC02	PANTOVER	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	739,113 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	727,019 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	294,302 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	440,780 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	837,214 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	4,146,714 L.L
A02BC02	PANTONIX-JULPHAR	G	Pantoprazole - 40mg	40mg	Injectable powder for solution	260,705 L.L
A02BC02	PANTOPRAZOL SALA	G	Pantoprazole (sodium) - 40mg	40mg	Injectable powder for solution	503,941 L.L
A02BC01	ARAPRIDE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
A02BC01	AXIPRON	G	Omeprazole - 20mg	20mg	Capsule	373,358 L.L
A02BC01	DIGCAP	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
A02BC01	EPIRAZOLE	G	Omeprazole - 20mg	20mg	Capsule	208,296 L.L
A02BC01	GASTRAZOLE	G	Omeprazole - 20mg	20mg	Capsule	134,384 L.L
A02BC01	GASTRAZOLE	G	Omeprazole - 20mg	20mg	Capsule	377,620 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	6,720,556 L.L
A02BC01	GASTRISEC	G	Omeprazole - 20mg	20mg	Capsule	413,903 L.L
A02BC01	HYPOSEC	G	Omeprazole - 20mg	20mg	Capsule	659,827 L.L
A02BC01	HYPOSEC	G	Omeprazole - 20mg	20mg	Capsule	1,478,227 L.L
A02BC01	MEDIZOLE GP	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	503,941 L.L
A02BC01	NEOOPRAZOLE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	407,184 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L

...

192